Impaired NK cytolytic activity and enhanced tumor growth in NK lytic-associated molecule-deficient mice.

The Journal of Immunology : Official Journal of the American Association of Immunologists
Richard G HooverJacki Kornbluth

Abstract

NK lytic-associated molecule (NKLAM) is a protein involved in the cytolytic function of NK cells. It is weakly expressed in resting NK cells but upon target cell stimulation or after incubation with cytokines that enhance NK killing, NKLAM mRNA levels increase and protein is synthesized and is targeted to cytoplasmic granule membranes. We have previously shown that NKLAM plays a role in perforin/granzyme-mediated cytolysis in vitro. To further investigate the function of NKLAM in NK cell-mediated cytotoxicity, we generated, by gene targeting, NKLAM-deficient mice. These mice have normal numbers of NK cells and other lymphoid populations in the spleen. They also have no alterations in NK maturation or NK receptor repertoire. NK cells from NKLAM-deficient and WT mice have comparable amounts of perforin, granzyme B, and lysosomal membrane-associated protein 1 (CD107a) in their cytotoxic granules and comparable levels of granule exocytosis are induced by PMA and calcium ionophore A23187. However, NKLAM-deficient NK cells display significantly less NK cytotoxic activity in vitro than WT NK cells. They also secrete less IFN-gamma upon target cell stimulation, In addition, NKLAM-deficient mice exhibit greater numbers of pulmonary meta...Continue Reading

References

May 1, 1991·The Journal of Experimental Medicine·P J PetersH J Geuze
Jul 1, 1985·The Journal of Cell Biology·J W ChenJ T August
Oct 2, 1981·Science·R B Herberman, J R Ortaldo
Jul 15, 1982·International Journal of Cancer. Journal International Du Cancer·E GorelikR B Herberman
Jul 28, 1999·Protein Science : a Publication of the Protein Society·B A van der ReijdenJ H Jansen
Mar 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·S KimW M Yokoyama
Jul 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·H AraseL L Lanier
Feb 28, 2002·Annual Review of Immunology·John H Russell, Timothy J Ley
May 15, 2002·Nature Immunology·Sungjin KimWayne M Yokoyama
Mar 23, 2004·Annual Review of Immunology·Yun-Cai Liu
Apr 27, 2004·Nature Immunology·Tsung-Hsien Chuang, Richard J Ulevitch
Jan 7, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Swapnil V VaidyaPorunelloor A Mathew
Oct 28, 2005·Essays in Biochemistry·Helen C Ardley, Philip A Robinson
Dec 15, 2005·The Journal of Experimental Medicine·Shihao ChenMinoru Fukuda
Jan 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yoshihiro Hayakawa, Mark J Smyth
May 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Julie M Fortier, Jacki Kornbluth
Mar 21, 2007·Genome Biology·Birgit EisenhaberMarie-Theres Hauser
May 18, 2007·Annual Review of Cell and Developmental Biology·Jane C Stinchcombe, Gillian M Griffiths
Oct 18, 2007·Journal of Leukocyte Biology·Yoshihiro HayakawaMark J Smyth
Sep 19, 2008·Nature Immunology·Morgan HuseMark M Davis
Feb 24, 2009·Blood·Laura ChiossoneThierry Walzer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

© 2022 Meta ULC. All rights reserved